(Q40012002)
Statements
Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicin (English)
Denis Ravel
Vincent Dubois
Jérôme Quinonero
Florence Meyer-Losic
Jeanpierre Delord
Céline Nicolazzi
Fabien Ribes
Catherine Mazerolles
Elise Assouly
Karine Vialatte
Inès Hor
Jonathan Kearsey